MX9700190A - Quimioprevencion de polipos colorrectales adenomatosos metacronosos. - Google Patents

Quimioprevencion de polipos colorrectales adenomatosos metacronosos.

Info

Publication number
MX9700190A
MX9700190A MX9700190A MX9700190A MX9700190A MX 9700190 A MX9700190 A MX 9700190A MX 9700190 A MX9700190 A MX 9700190A MX 9700190 A MX9700190 A MX 9700190A MX 9700190 A MX9700190 A MX 9700190A
Authority
MX
Mexico
Prior art keywords
metachronous
chemoprevention
colorectal polyps
adenomatous colorectal
adenomatous
Prior art date
Application number
MX9700190A
Other languages
English (en)
Other versions
MXPA97000190A (es
Inventor
Mark V Larson
David A Ahlquist
Randall K Pearson
Original Assignee
Mayo Foundation
And Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation, And Res filed Critical Mayo Foundation
Publication of MX9700190A publication Critical patent/MX9700190A/es
Publication of MXPA97000190A publication Critical patent/MXPA97000190A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona un método para proteger a un colorrecto contra una recurrencia de adenomas, en donde se administra ácido ursodesoxicolico, o ácido ursodesoxicolico en combinacion con sulindac, a un paciente afligido con adenomas colorrectales, en una cantidad efectiva para prevenir la recurrencia de adenomas colorrectales en seguida de su remocion.
MXPA/A/1997/000190A 1996-03-22 1997-01-07 Quimioprevencion de polipos colorrectales adenomatosos metacronosos MXPA97000190A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/621,781 US5843929A (en) 1996-03-22 1996-03-22 Chemoprevention of metachronous adenomatous colorectal polyps
US08621781 1996-03-22

Publications (2)

Publication Number Publication Date
MX9700190A true MX9700190A (es) 1997-11-29
MXPA97000190A MXPA97000190A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
CA2193579A1 (en) 1997-09-23
US5814625A (en) 1998-09-29
US5843929A (en) 1998-12-01

Similar Documents

Publication Publication Date Title
HK1052708B (zh) 谷氨酰胺-四氫噻唑和四氫化吡咯及其作為二肽基肽酶iv抑制劑的應用
PL352712A1 (en) Method for treating chronic pain using mek inhibitors
EP0935415A4 (en) METHOD FOR MAKING CONNECTIONS INTO A CELL
IL114294A0 (en) Sterol derivatives
AU2001257342A1 (en) Treatment well tiltmeter system
NO994309L (no) Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner
HK1011024A1 (en) Phosphorus derivatives to treat aids.
WO2001043782A3 (en) Radiation source module
AU2156000A (en) Liquid urea exhaust gas treatment additive
AU4830097A (en) Use of an extract of Cimicifuga
WO2001006990A3 (en) Use of etodolac to treat cancer
HK1028615A1 (en) Isolated nona-and decapeptides which bind to hla molecules, and the use thereof
AU4640997A (en) Use of an H+, K+-ATPase inhibitor in the treatment of nasal polyps
AU2001281095A1 (en) Method and system for reducing the time required to power down engine controllerwith faulty eeprom
AU8239298A (en) Nucleotide-comprising composition
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
MX9700190A (es) Quimioprevencion de polipos colorrectales adenomatosos metacronosos.
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
WO1997034627A3 (en) Protection of hemopoietic cells during chemotherapy or radiotherapy
AU3108200A (en) Methods to reduce variance in treatment studies using genotyping
AU9294698A (en) Methods and compositions for enhanced wound healing
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
BG101526A (en) Antiphlogistic composition for external application
MY118982A (en) Method of reducing tissue damage associated with ischemia

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees